Lamia M. Aljaiar & Fadwa M. Alahmadi
Madinah Maternity and Children Hospital, KSA
Title: Bakri balloon for the management of placenta previa
Biography
Biography: Lamia M. Aljaiar & Fadwa M. Alahmadi
Abstract
Introduction; Placenta previa is frequently associated with severe obstetric hemorrhage. Bakri balloon was used for the first time in 1992, and was approved as one of the primary support tools in treating PPH.
Objective; To evaluate the outcomes of uterine tamponade using a Bakri balloon for management of placenta previa during caesarean deliveries.
Methods; This is a retrospective study carried out in Maternity and Children Hospital (MCH), Madinah, Saudi Arabia, from September 2012 to September 2015. Outcomes include demographic characteristics of the participants, need for blood transfusion, failure of the balloon, need for further management, duration the balloon kept in, obstetric complications, neonatal morbidity, hospital course post-operative, follow up and progress afterward.
Results; Total number of placenta previa patients 225, of these 164 were operated, while, 47 were transferred to higher medical centre. Added to that, 14 patients were discharged against medical advice. 13 Bakri balloon were inserted intraoperative.
Conclusion; Bakri balloon was more effective in controlling bleeding and was associated with less maternal morbidity and mortality than not using the balloon.
This is the only study in the Middle East which study Bakri balloon for the management of placenta previa.